In February 2022, scientists from the Beth Israel Deaconess Medical Center, Departments of Internal Medicine, Clinical Pathology, Gynecologic Oncology, and Oncology, and Tufts University School of Medicine, Department of Surgical Oncology presented two patients who had recurrent cervical adenocarcinoma with peritoneal carcinomatosis and were treated with hyperthermic intraperitoneal chemotherapy (HIPEC). The full manuscript by Taliya…